ArticleJournal of atrial fibrillation

Validation Of The HAS-BLED Tool In Atrial Fibrillation Patients Receiving Rivaroxaban.

E W Gorman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.